Tumor budding in cervical carcinoma: associations with some clinical and pathological factors

  • Nevena Stanulović Oncology Institute of Vojvodina Put dr Goldmana 4 Sremska Kamenica
  • Tatjana Ivković-Kapicl 1. Oncology Institute of Vojvodina Put dr Goldmana 4 Sremska Kamenica 2. University of Novi Sad, Faculty of Medicine Hajduk Veljkova 3 Novi Sad
  • Aljoša Mandić 1. Oncology Institute of Vojvodina Put dr Goldmana 4 Sremska Kamenica 2. University of Novi Sad, Faculty of Medicine Hajduk Veljkova 3 Novi Sad
  • Bojana Gutić 1. Oncology Institute of Vojvodina Put dr Goldmana 4 Sremska Kamenica 2. University of Novi Sad, Faculty of Medicine Hajduk Veljkova 3 Novi Sad
Keywords: cervix, cancer, tumor budding, cell dissociation

Abstract


Background: Tumor budding is recognized as an important independent prognostic factor in colorectal carcinoma. The aim of this study was to evaluate the grade of tumor budding and association with other clinical and pathological features in patients with cervical carcinoma. Material and methods: We evaluated pathohistological data from 91 cervical carcinoma patients (mean age: 53.8 years) who underwent radical hysterectomy and pelvic lymphatic dissection at the Oncology Institute of Vojvodina between January 2010 and December 2018. Tumor budding was evaluated in invasive front of the tumor. Based on the number of bud counts/10 high power field, three groups were formed: with no budding, with less than 15 buds, and with more than 15 buds. Results: Eighty (87.91%) of evaluated cervical carcinomas were squamous-cell type, while 12.09% were adenocarcinomas. All carcinomas were graded (HG1-HG3). Average diameter of the tumors was 25 mm (81.6% < 4 cm and 18.4% > 4 cm). Metastases in lymph nodes were present in 30 (32.9%) cases. Based on the number of bud counts/10 high power field there were 35.1% with no budding, 32.9% with less than 15 buds and 37.3% with more than 15 buds. There was a significant association between tumor budding grade and histological grade (p=0.04), as well as with tumor budding grade and the diameter of the tumor (p=0.04). Conclusion: As a quantitative measure of cancer cell dissociation, tumor budding is associated with
poor prognosis in cervical carcinoma and should be considered as a prognostic factor.

References

Tarkan Jäger, Daniel Neureiter, Mohammad Fallaha et al. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. Strahlenther Onkol (2018) 194:991–1006.

European Cancer Information System. https://ecis.jrc.ec.europa.eu (September 2019, last date accessed).

Chen Li, Wenhui Liu, Yufeng Cheng. Prognostic significance of metastatic lymph node ratio in squamous cell carcinoma of the cervix. OncoTargets and Therapy 2016:9 3791–3797.

Roma AA, Diaz De Vivar A, Park KJ, et al (2015). Invasive endocervical adenocarcinoma: A new pattern-based classification system with important clinical significance. Am J Surg Pathol, 39, 667-72.

Shuang Zhao, Xuelian Zhao, Shangying Hu et al. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China. Chin J Cancer Res. 2019 Aug; 31(4): 663–672.

Moritz Jesinghaus, Johanna Strehl, Melanie Boxberg et al. Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix. J Path: Clin Res April 2018; 4: 93–102.

Bichel P, Jakobsen A. Histopathologic grading and prognosis of uterine cervical carcinoma. Am J Clin Oncol 1985; 8: 247–254.

Kristensen GB, Abeler VM, Risberg B, et al. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol 1999; 74: 245–251.

Stendahl U, Eklund G, Willen R. Invasive squamous cell carcinoma of the uterine cervix. IV. Analysis of a histopathologic malignancy grading system and construction of a partial index. Acta Radiol Oncol 1981; 20: 289–284.

Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO Classification of Tumours of Female Reproductive Organs. International Agency for Research on Cancer: Lyon, 2014.

Horn LC, Fischer U, Raptis G, et al (2006a). Pattern of invasion is of prognostic value in surgically treated cervical cancer patients. Gynecol Oncol, 103, 906-11.

Shota Shimizu, Akihiro Miyazaki, Tomoko Sonoda. Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion. PLoS ONE 13(4): e0195451.

Park JH, van Wyk H, Roxburgh CSD, Horgan PG, Edwards J, McMillan DC. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer. Br J Cancer 2017; 116(11):1444–1450.

Brierley J, Gospodarowicz M, Wittekind C et al. TNM classification of malignant tumours. 8th ed. Hoboken, NJ: John Wiley & Sons, Inc., 2017.

Meral Koyuncuoglu, Emre Okyay, Bahadir Saatli et al. Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?. M. Koyuncuoglu et al. / Gynecologic Oncology 125 (2012) 208–213.

Diaz De Vivar A, Roma AA, Park KJ, et al (2013). Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study. Int J Gynecol Pathol, 32, 592-601.

Baalbergen A, Ewing-Graham PC, Hop WC, et al (2004). Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol, 92, 262-7.

Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H. Tumor Budding: The Name is EMT. Partial EMT. J Clin Med 2016; 5.

Ioannis A Voutsadakis. Prognostic role of tumor budding in breast cancer. World J Exp Med 2018 September 7; 8(2): 12-17.

Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007;50(1):151–62.

Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 2003; 83: 42–7.

M. S. Roh, J. I. Lee,P. J. Choi et al. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Diseases of the Esophagus (2004) 17, 333–337.

Tanaka M, Hashiguchi Y, Ueno H, Hase K, Mochizuki H. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis Colon Rectum 2003; 46: 1054–9.

Choi HJ, Park KJ, Shin JS, Roh MS, Kwon HC, Lee HS. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int J Colorectal Dis 2007;22(8):863–8.

Kanazawa H, Mitomi H, Nishiyama Y, Kishimoto I, Fukui N, Nakamura T, et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis 2008;10(1):41–7.

Roh MS, Lee JI, Choi PJ. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 2004;17(4):333–7.

Sarioglu S, Acara C, Akman FC, Dag N, Ecevit C, Ikiz AO, et al. Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol Res Pract 2010;206(2):88–92.

Nopporn Satabongkoch, Surapan Khunamornpong et al. Prognostic Value of Tumor Budding in Early-Stage Cervical Adenocarcinomas. Asian Pac J Cancer Prev, 18 (6), 1717-1722.

Zlobec,M Hädrich,H Dawson,V H Koelzer et al. Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br J Cancer. 2014 Feb 18; 110(4): 1008–1013.

Landau MS, Hastings SM, Foxwell TJ, et al (2014). Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol, 27, 1578-89.

Mitrovic B, Schaeffer DF, Riddell RH, et al (2012). Tumor budding in colorectal carcinoma: time to take notice. Mod Pathol, 25, 1315-25.

Pongsuvareeyakul T, Khunamornpong S, Settakorn J, et al. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery. Asian Pac J Cancer Prev, 16, 4363-8.

Bangxing Huang,, Jing Cai, Xia Xu. High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk. PloS ONE 11(11): e0166311.

Published
2020/08/12
Section
Original Scientific Paper